By Emma Farge GENEVA, July 27 (Reuters) - The world risks a resurgence of the HIV epidemic after global funding fell by ...

Funding for the global HIV response plunged in 2025, entirely due to a steep decline in U.S. support, according to reports ...

The world’s richest man has passed a “slow death sentence” on thousands of people with HIV by cutting US spending on the ...

Although new HIV infections and AIDS-related deaths are at their lowest levels in more than 30 years, the current HIV response is extremely fragile. Efforts to end AIDS as a public health threat by ...

The AIDS epidemic could stage a comeback amid unequal access to breakthrough prevention medicines and a sharp decline in ...

Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its ...

There are plenty of unknowns when starting your HIV prevention journey. What to take, how to get care, what to believe, and ...

The Trump administration's cuts to the U.S. Agency for International Development and thousands of global health grants have ...

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...

At least 78 children in Sindh, Pakistan, have been infected with HIV amid allegations of unsafe injection practices. Samaan Lateef reports.

As HIV/AIDS enters its fifth decade, Black women's leadership offers urgent lessons about public health, community care, and ...